We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Image of Michele Trott, PhD

Michele Trott, PhD


Michele Trott (nee Wilson) is a New Zealand-based science writer who pursues freelance writing projects alongside her in-house role as a scientific content writer at Izon Science. After completing her PhD (Endocrinology) at Lincoln University (NZ), Michele began pursuing her science writing career with Technology Networks in the UK. There, she spent 12 months covering a maternity leave role as a science editor, and managed the cell science, biopharma and diagnostics communities. Upon her arrival back in NZ, Michele established “Choice Science Writing” and became a full-time freelance science writer, working with life science marketing agencies, biotech companies – and of course, Technology Networks – to produce engaging articles and blog posts. In April 2021, she took up the opportunity to join the team at Izon Science, a company that enables the precise separation and analysis of extracellular vesicles and other nanoparticles.


Got a Question for Michele Trott, PhD?


Get in touch using the contact form linked here and we’ll get back to you shortly



Published Content
Total: 111
Cell Conversions Transformed From Black Box Guesswork to Systematic Discovery content piece image
Industry Insight

Cell Conversions Transformed From Black Box Guesswork to Systematic Discovery

Predicting the reprogramming factors necessary to induce cell conversion has largely relied on trial and error, revealing the need for a more systematic approach. To learn about Mogrify's approach to achieving cell conversion through transdifferentiation, we interviewed Pierre-Louis Joffrin, Corporate Development Executive at Mogrify.
10 Things to Note About Manufacturing Viral Vectors content piece image
Industry Insight

10 Things to Note About Manufacturing Viral Vectors

10 things to note about viral vector manufacturing, regarding the complexities and challenges, and the technology that will help drive cell and gene therapy forward. Here we share insights from Pall and Molmed representatives, who are leaders in the fields of bioprocessing and cell and gene therapy.
Concepts and Promises of Personalized Medicine content piece image
Infographic

Concepts and Promises of Personalized Medicine

What is personalized medicine (PM) and why do we need it? Download this infographic to learn about PM, a movement with the potential to help match patients to therapies far more efficiently than the current “trial and error” approach.
Cryopreservation: Key Principles and Applications content piece image
Infographic

Cryopreservation: Key Principles and Applications

Cryopreservation, the use of very low temperatures and cryoprotectants to preserve structurally intact cells and tissues, is essential to many areas of research and medicine. Find out why cryopreservation is used, how cryoprotectants reduce cell shrinkage, and learn about the therapies dependent on successful cryopreservation.
Talking NGS, Liquid Biopsies and Tumor Mutational Burden With Luca Quagliata content piece image
Industry Insight

Talking NGS, Liquid Biopsies and Tumor Mutational Burden With Luca Quagliata

We recently spoke with Luca Quagliata, Ph.D., Global Director of Medical Affairs for Thermo Fisher Scientific. Previously, Quagliata was involved in one of the first teams in Europe to introduce Next Generation Sequencing (NGS) in routine molecular diagnostics. Here, he shares his perspectives on the field, particularly the use of NGS in the analysis of liquid biopsies, the discovery of cancer biomarkers and the potential application of artificial intelligence (AI) in molecular diagnostics.
App Alerts Hospital Staff to Potentially Fatal Kidney Condition in Minutes content piece image
News

App Alerts Hospital Staff to Potentially Fatal Kidney Condition in Minutes

A mobile phone app has been developed to inform doctors and nurses of patients with acute kidney injury, a potentially fatal condition. The app reduces the time it takes for hospital staff to become aware of critical blood test results, from hours to minutes.
Imagine Collaboration, Without the Faff content piece image
Industry Insight

Imagine Collaboration, Without the Faff

Imagine if there was a better way to write, format, and review scientific manuscripts for publication. doDOC Document Collaboration Expert Leif Måsvær believes there is. Leif explains how this cloud-based platform is a game-changer that overcomes the major obstacles present during the authoring, writing, and reviewing process.
Leading Minds Reflect On How the World Feels About Science and Health content piece image
Article

Leading Minds Reflect On How the World Feels About Science and Health

Gauging global attitudes to science and health is no easy task, but it was the goal of The Wellcome Global Monitor – a survey of over 140,000 people aged 15 and older, from more than 140 countries. The findings present an unprecedented view of the relationship between science and society worldwide, which were discussed by leaders at the launch event in Washington D.C.
Authors' Perspectives: Cell Size Sparks Embryonic Genome Awakening content piece image
Article

Authors' Perspectives: Cell Size Sparks Embryonic Genome Awakening

At some point in the early life of an embryo, zygotic nuclei "wake up" and take control of subsequent embryo development. As featured on the cover of Developmental Cell, a new study provides evidence supporting the hypothesis that cell size is the principal determinant of this transition from maternal to embryonic control. We spoke to a few of the co-authors to learn more about this important finding.
Zika vs Dengue: Minimizing Cross-reactivity in Immunoassay Development content piece image
Industry Insight

Zika vs Dengue: Minimizing Cross-reactivity in Immunoassay Development

The Zika virus poses a significant global risk, and there is currently no vaccine or specific treatment available for those infected. Having access to sensitive and specific diagnostic assays is essential to disease management, and in enabling effective research and the development of therapeutics. We spoke to Nick Roesen, Founder and COO of The Native Antigen Company, to learn about the Zika virus immunoassays that have been developed to overcome cross-reactivity with Dengue.
Advertisement